Proteomic analysis reveals sex-specific biomarker signature in postural  orthostatic tachycardia syndrome, BMC Cardiovascular Disorders

Proteomic analysis reveals sex-specific biomarker signature in postural orthostatic tachycardia syndrome, BMC Cardiovascular Disorders

5
(77)
Write Review
More
$ 18.00
Add to Cart
In stock
Description

Background Postural orthostatic tachycardia syndrome (POTS) is a variant of cardiovascular (CV) autonomic disorder of unknown etiology characterized by an excessive heart rate increase on standing and orthostatic intolerance. In this study we sought to identify novel CV biomarkers potentially implicated in POTS pathophysiology. Methods We conducted a nested case-control study within the Syncope Study of Unselected Population in Malmö (SYSTEMA) cohort including 396 patients (age range, 15–50 years) with either POTS (n = 113) or normal hemodynamic response during passive head-up-tilt test (n = 283). We used a targeted approach to explore changes in cardiovascular proteomics associated with POTS through a sequential two-stage process including supervised principal component analysis and univariate ANOVA with Bonferroni correction. Results POTS patients were younger (26 vs. 31 years; p < 0.001) and had lower BMI than controls. The discovery algorithm identified growth hormone (GH) and myoglobin (MB) as the most specific biomarker fingerprint for POTS. Plasma level of GH was higher (9.37 vs 8.37 of normalised protein expression units (NPX); p = 0.002), whereas MB was lower (4.86 vs 5.14 NPX; p = 0.002) in POTS compared with controls. In multivariate regression analysis, adjusted for age and BMI, and stratified by sex, lower MB level in men and higher GH level in women remained independently associated with POTS. Conclusions Cardiovascular proteomics analysis revealed sex-specific biomarker signature in POTS featured by higher plasma level of GH in women and lower plasma level of MB in men. These findings point to sex-specific immune-neuroendocrine dysregulation and deconditioning as potentially key pathophysiological traits underlying POTS.

Circulating levels of growth hormone in postural orthostatic tachycardia syndrome

BMC Cardiovascular Disorders 1/2020

Frontiers COVID-19 and the Vasculature: Current Aspects and Long-Term Consequences

1-L Transcription in Parkinson's Disease

Frontiers ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature

Frontiers The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches

Quantitative proteomic analysis of human serum using tandem mass tags to predict cardiovascular risks in patients with psoriasis

Baroreflex control of muscle sympathetic nerve activity in postural orthostatic tachycardia syndrome

Dr. Artur Fedorowski Publications

Quantitative proteomic analysis of human serum using tandem mass tags to predict cardiovascular risks in patients with psoriasis